Throughout 37 CFR 1.823(b), the items of information relating to patent applications and patent publications should be provided keeping in mind the appropriate standards that have been established by the World Intellectual Property Organization (WIPO). In general, an application should be identified by a country code, a number and a filing date, while a published patent document should be identified by a country code, a number and kind code. Proper citation of priority patent applications is covered in MPEP § 214.04. For published patent documents, the country code, number and kind code will appear on the front page of the document. Unpublished PCT applications are identified by the letters PCT, the country code of the Receiving Office, and either the last two digits of the year of filing and a number, e.g., PCT/AT81/00033 or PCT/FR88/00100, or the four digit year of filing and a six digit number, e.g., PCT/SE2011/000123. A published PCT application is identified by the letters WO, the last two digits of the year of publication, a number and a kind code, e.g., WO82/02827A or WO88/06811A, or by the letters WO, the four digit year of publication and a six digit number, e.g. WO/2015/009167. Country codes from WIPO Standard ST.3 Annex A and kind codes from WIPO Standard ST.16 are reproduced in MPEP § 1851. Questions on proper citation of patent documents should be directed to staff in the Office of International Patent Cooperation.
In 37 CFR 1.823(b), numeric identifier <110>, the item of information relating to “Applicant” should be limited to a maximum of the first ten named applicants in the application. Similarly, in numeric identifier <301>, the item of information relating to “Authors” should be limited to a maximum of the first ten named authors in the publication.
In 37 CFR 1.823(b) “yyyy-mm-dd” is the format for the presentation of patent related date information in the sequence listing. Other date information may also be presented as MMM-yyyy or Season-yyyy. The lower case letters designate numeric responses and the upper case letters designate alphabetical responses. As such, March 2, 1988, would be presented as 1988-03-02 or MAR 1988.
In numeric identifiers <220> – <223>, relating to “Features” or the description of the points of biological significance in a given sequence, it is recommended, but not required, that the information that is provided by the applicant conform to the controlled vocabulary that is set forth in the DDBJ/EMBL/GenBank FeatureTable Definition provided by the International Nucleotide Sequence Data Collaboration (INSDC) at www.insdc.org/documents. See MPEP § 2422 when filing in countries which adhere to WIPO Standard ST.25.
In numeric identifiers <300> – <312>, publication information for a given sequence is collected. The publication information encompasses both patent-type publications and non-patent literature publications. Numeric identifier <313>, Relevant Residues, is intended to collect information relating to the correspondence between a sequence set forth in the sequence listing and published sequence information. The starting (FROM) and end (TO) positions in the listed sequence that correspond to the published sequence information should be set forth.